Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care

Highlights • DIABSCORE was developed and validated an risk score for screening of type 2 diabetes in a general population cohort. • DIABSCORE showed a high sensitivity to detect cases of type 2 diabetes and a high negative predictive value to rule out the presence of diabetes. • DIABSCORE has showed to be a valid method for opportunistic screening of type 2 diabetes in primary care that is applicable in different populations. • DIABSCORE does not require invasive methods and competes advantageously with blood glucose and HbA1c in terms of patient and professional satisfaction. • DIABSCORE is a cost-effective screening method for type 2 diabetes in primary care compared to the use of blood glucose or HbA1c.